BRFS News and Press, BRF S.A. From 03/04/24

2024-03-04 03:30:02 ET Barclays analyst issues OVERWEIGHT recommendation for BRFS on March 4, 2024 02:38AM ET. BRFS was trading at $3.01 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst recommendations are : 2 - Buy, 5 - Hold,...

SUIC Worldwide Holdings Ltd (SUIC) is expected to report for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 uniQure N.V. (QURE) is expected to report $-1.54 for Q4 2023 Albany International Corporation (AIN) is expected to report $0.84 for Q4 2023 I...

2024-01-30 09:37:49 ET Summary BRF's stock is not recommended due to poor past capital allocation decisions, high leverage levels, and lack of business diversification. JBS and Minerva are preferred investment opportunities over BRF. BRF's operational performance has been weak...

2024-01-13 10:04:38 ET More on Pilgrim's Pride and Tyson Foods One Dividend Contender To Buy And One Dividend Pretender To Avoid In 2024 Tyson Foods: Overvalued Amid Prolonged Margin Compression Pilgrim's Pride: Gaining Momentum But Heavy Overhead Resistance Ahead ...

2023-12-27 12:17:47 ET More on iShares MSCI World Index ETF: 24 global single name stock longs for 2024 - Morgan Stanley U.S. equities continue to lead the world in inflows, China sees large outflows Dividend scorecard for iShares MSCI World Index ETF For fur...

2023-11-14 16:23:07 ET BRF S.A. (BRFS) Q3 2023 Results Conference Call November 14, 2023 08:30 AM ET Company Participants Miguel Gularte - Chief Executive Officer Fabio Mariano - Chief Financial Officer Conference Call Participants Ricardo Alves - Morgan ...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

2023-11-08 10:45:57 ET More on Consumer Staples The Consumer Staples Select Sector SPDR Fund ETF Is Due For A Massive Rebound XLP: I'd Rather Have Coal In My Stocking Seeking Alpha’s Quant Rating on Consumer Staples Select Sector SPDR ETF For further d...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

2023-11-06 10:59:07 ET More on Consumer Staples The Consumer Staples Select Sector SPDR Fund ETF Is Due For A Massive Rebound XLP: I'd Rather Have Coal In My Stocking Stocks to watch out for in the Consumer Staples sector ahead of earnings Seeking Alpha's qua...